Getting started · 01

How Research Protocol Builder works

Research Protocol Builder helps you turn a question into a written plan, keep an honest record while you follow it, and look back at what actually happened. It is a notebook with structure, not a source of advice.

3 min read · EN ES DE FR PT IT NL PL ZH
CC BY-NC-SA 4.0

The loop

  1. Start with a question

    For example: “Does knee pain on stairs change over eight weeks?” A clear question decides everything that follows.

  2. Read the evidence

    Each peptide in the library has a profile with an evidence grade, the studies behind it, safety notes, and the markers researchers watch.

  3. Write the protocol

    The builder walks you through five steps: goal, peptides, schedule, what to track, and review.

  4. Record a baseline

    Log your chosen metrics for a week or two before you start. That is what everything later is compared against.

  5. Log as you go

    Doses, metrics, side effects and short observations. A minute a day.

  6. Review and revise

    At the checkpoints in your plan, look at the charts against your . Any change you make is saved as a new version, so the history stays honest.


Where things live

My research is your dashboard: today’s doses, recent entries, forum replies and updates to the peptides you follow.

Protocols holds every plan and its version history. Log is the daily record and its charts. Assistant reads your lab reports and answers questions from the library. Community and Forum are where members compare notes.


What stays private

Protocols, logs, medications and lab results are health data. They are stored in the EU, encrypted with a key unique to you, and kept apart from your email address. Staff cannot open them.

Nothing is shared unless you share it: a read-only link that expires, a clinician view, or an anonymous copy published to Community Protocols.


What it is not

Research Protocol Builder is an educational resource. It does not diagnose, prescribe or recommend doses, and it does not sell anything. Many peptides discussed here are not approved for human use; check the rules where you live, and involve a clinician.